Hyperbilirubinemia in the Newborn Infant ≥35 Weeks’ Gestation: An Update With Clarifications-Reference-Cited by-同舟云学术

Hyperbilirubinemia in the Newborn Infant ≥35 Weeks’ Gestation: An Update With Clarifications

Published:2009-10-01 Issue:4 Volume:124 Page:1193-1198
ISSN:0031-4005
Container-title:Pediatrics
language:en
Short-container-title:

Author:

Maisels M. Jeffrey¹,Bhutani Vinod K.²,Bogen Debra³,Newman Thomas B.⁴,Stark Ann R.⁵,Watchko Jon F.⁶

Affiliation:

1. Department of Pediatrics, Oakland University William Beaumont School of Medicine and Division of Neonatology, Beaumont Children's Hospital, Royal Oak, Michigan

2. Department of Neonatal and Developmental Medicine, Lucile Salter Packard Children's Hospital, Stanford University, Palo Alto, California

3. Division of General Academic Pediatrics, Department of Pediatrics, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

4. Department of Epidemiology and Biostatistics, Department of Pediatrics, University of California, San Francisco, California

5. Department of Pediatrics and Section of Neonatology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas

6. Division of Newborn Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Link

https://publications.aap.org/pediatrics/article-pdf/124/4/1193/1011585/zpe01009001193.pdf

Reference26 articles.

1. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics. 2004;114(4):1138]. Pediatrics. 2004;114(1):297–316

2. Canadian Paediatric Society, Fetus and Newborn Committee. Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks’ gestation). Paediatr Child Health. 2007;12(5):1B–12B

3. Sgro M, Campbell DM, Fallah S, Shah V. Kernicterus, January 2007 to December 2009. Canadian Paediatric Surveillance Program 2008 Results. Available at: www.cps.ca/english/surveillance/CPSP/index.htm. Accessed July 30, 2009

4. Manning D, Todd P, Maxwell M, Platt MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed. 2007;92(5):F342–F346

5. Bartmann P, Schaaff F. Kernicterus in Germany 2003–2005. E-PAS. 2007;617936.23

Cited by 396 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing neonatal hyperbilirubinemia;JAAPA;2024-09-11

2. Neues zum alten Thema Neugeborenenikterus;Neonatologie Scan;2024-08-20

3. Bilirubin measurements in neonates: uniform neonatal treatment can only be achieved by improved standardization;Clinical Chemistry and Laboratory Medicine (CCLM);2024-07-26

4. Evaluation of alanine aminotransferase/aspartate aminotransferase ratio and high-density lipoprotein for predicting neonatal adverse outcomes associated with intrahepatic cholestasis of pregnancy;PeerJ;2024-06-24

5. Yenidoğan Hiperbilirübinemisinde Kan Değişimi: 5 Yıllık Deneyimimiz;İzmir Tıp Fakültesi Dergisi;2024-06-21